These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 1143978
1. The timing of tuberculin tests in relation to immunization with live viral vaccines. Brickman HF, Beaudry PH, Marks MI. Pediatrics; 1975 Mar; 55(3):392-6. PubMed ID: 1143978 [Abstract] [Full Text] [Related]
4. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella]. Just M, Berger R, Glück R, Wegmann A. Schweiz Med Wochenschr; 1985 Nov 30; 115(48):1727-30. PubMed ID: 4081704 [Abstract] [Full Text] [Related]
5. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E, Tischer A. Gesundheitswesen; 1993 Jan 30; 55(1):38-9. PubMed ID: 8435543 [Abstract] [Full Text] [Related]
6. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M. Biken J; 1986 Dec 30; 29(3-4):63-71. PubMed ID: 3304276 [Abstract] [Full Text] [Related]
9. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps]. Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G. Minerva Pediatr; 1989 Mar 30; 41(3):117-22. PubMed ID: 2747598 [Abstract] [Full Text] [Related]
10. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population]. Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G. Przegl Epidemiol; 2003 Mar 30; 57(2):281-8. PubMed ID: 12910596 [Abstract] [Full Text] [Related]
11. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M. An Esp Pediatr; 1987 Jul 30; 27(1):27-31. PubMed ID: 3662251 [Abstract] [Full Text] [Related]
12. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 30; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related]
13. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC, Burgess MA, O'Brien ED. Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
14. Combination measles, mumps, rubella and varicella vaccine. Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA. Pediatrics; 1986 Oct 06; 78(4 Pt 2):742-7. PubMed ID: 3763291 [Abstract] [Full Text] [Related]
20. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus. Samoilovich EO, Kapustik LA, Feldman EV, Yermolovich MA, Svirchevskaya AJ, Zakharenko DF, Fletcher MA, Titov LP. Cent Eur J Public Health; 2000 Aug 06; 8(3):160-3. PubMed ID: 10965439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]